As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.
Related Posts
European stocks look set to build momentum after lackluster start to the week
Regional bourses are heading for a positive open Tuesday, looking to build some positive momentum after a muted trading session for equity markets on Monday.
Stock futures tick lower as S&P 500 closes out second year in a row with 20% gain: Live updates
The S&P has surged more than 24% this year, on pace for its second consecutive annual gain above 20%.